Stay updated on Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page
- Check5 days agoChange DetectedRecruitment status updated to indicate no further participant enrollment. New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting along with a footer revision tag were updated.SummaryDifference0.4%

- Check12 days agoChange DetectedRevision: v3.5.5 has been added, replacing the previous Revision: v3.5.4. This reflects a minor site update rather than a modification to the study details or information presented on the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA new page revision tag was added (v3.5.4) to the study details page, replacing the previous revision tag (v3.5.3). This signals an update to the page version.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s footer revision/version was updated from v3.5.2 to v3.5.3, indicating a site software/content-management release rather than a change to the underlying study details.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Betalutin in Relapsed/Refractory Non-Hodgkin Lymphoma Clinical Trial page.